Published in Am J Respir Crit Care Med on April 15, 2013
Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64
ESR/ERS white paper on lung cancer screening. Eur Respir J (2015) 2.87
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. Am J Respir Crit Care Med (2015) 1.48
Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest (2015) 1.11
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax (2015) 1.08
The Swedish CArdioPulmonary BioImage Study: objectives and design. J Intern Med (2015) 0.98
Validation of a blood protein signature for non-small cell lung cancer. Clin Proteomics (2014) 0.95
Lung cancer screening with low-dose computed tomography for primary care providers. Prim Care (2014) 0.90
Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials. Cancer Epidemiol Biomarkers Prev (2014) 0.82
ESR/ERS white paper on lung cancer screening. Eur Radiol (2015) 0.80
Spectrum of early lung cancer presentation in low-dose screening CT: a pictorial review. Insights Imaging (2016) 0.80
Cardiac valve calcifications on low-dose unenhanced ungated chest computed tomography: inter-observer and inter-examination reliability, agreement and variability. Eur Radiol (2014) 0.80
Is volumetric 3-dimensional computed tomography useful to predict histological tumour invasiveness? Analysis of 211 lesions of cT1N0M0 lung adenocarcinoma. Interact Cardiovasc Thorac Surg (2016) 0.79
Stage shift in computed tomography screening: possible role of indolent cancers, "histology shift," and overdiagnosis. Am J Respir Crit Care Med (2013) 0.79
CT Imaging Features in the Characterization of Non-Growing Solid Pulmonary Nodules in Non-Smokers. Pol J Radiol (2016) 0.79
Update in Lung Cancer 2014. Am J Respir Crit Care Med (2015) 0.79
Missed lung cancer: when, where, and why? Diagn Interv Radiol (2017) 0.78
Favorable stage distribution in the NELSON trial: promise or hype? Am J Respir Crit Care Med (2013) 0.78
Prognostic value of heart valve calcifications for cardiovascular events in a lung cancer screening population. Int J Cardiovasc Imaging (2015) 0.77
Serum calprotectin, CD26 and EGF to establish a panel for the diagnosis of lung cancer. PLoS One (2015) 0.77
Subsolid pulmonary nodule morphology and associated patient characteristics in a routine clinical population. Eur Radiol (2016) 0.77
Indeterminate pulmonary nodules: risk for having or for developing lung cancer? Cancer Prev Res (Phila) (2014) 0.77
Distribution of Solid Solitary Pulmonary Nodules within the Lungs on Computed Tomography: A Review of 208 Consecutive Lesions of Biopsy-Proven Nature. Pol J Radiol (2016) 0.75
Update in Lung Cancer 2015. Am J Respir Crit Care Med (2016) 0.75
Small pulmonary nodules in baseline and incidence screening rounds of low-dose CT lung cancer screening. Transl Lung Cancer Res (2017) 0.75
Reply: stage distribution of lung cancers detected by computed tomography screening in the NELSON Trial. Am J Respir Crit Care Med (2013) 0.75
Current Trends of Lung Cancer Surgery and Demographic and Social Factors Related to Changes in the Trends of Lung Cancer Surgery: An Analysis of the National Database from 2010 to 2014. Cancer Res Treat (2016) 0.75
Implementation and organization of lung cancer screening. Ann Transl Med (2016) 0.75
Risk factors assessment and risk prediction models in lung cancer screening candidates. Ann Transl Med (2016) 0.75
Implementing lung cancer screening in the real world: opportunity, challenges and solutions. Transl Lung Cancer Res (2015) 0.75
Efficacy of low-dose computed tomography screening for lung cancer: the current state of evidence of mortality reduction. Surg Today (2016) 0.75
Screening and prostate-cancer mortality in a randomized European study. N Engl J Med (2009) 35.94
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Prostate-cancer mortality at 11 years of follow-up. N Engl J Med (2012) 16.91
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. N Engl J Med (2015) 11.98
Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst (2003) 11.27
Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med (2004) 8.91
Quality-of-life effects of prostate-specific antigen screening. N Engl J Med (2012) 7.21
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Management of lung nodules detected by volume CT scanning. N Engl J Med (2009) 6.79
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med (2010) 6.39
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med (2009) 4.60
Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet (2003) 4.20
Trans-eQTLs reveal that independent genetic variants associated with a complex phenotype converge on intermediate genes, with a major role for the HLA. PLoS Genet (2011) 3.65
Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089). J Clin Oncol (2013) 3.63
Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J (2005) 3.58
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet (2010) 3.55
Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Ann Intern Med (2014) 3.46
Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation (2005) 3.28
Cerebral white matter lesions and the risk of dementia. Arch Neurol (2004) 3.17
Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med (2012) 3.05
Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2002) 3.00
FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity. J Cell Biol (2002) 2.86
Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med (2013) 2.77
Lung function decline in male heavy smokers relates to baseline airflow obstruction severity. Chest (2012) 2.77
The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study. J Am Coll Cardiol (2002) 2.74
Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. Arch Pathol Lab Med (2013) 2.66
The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer (2012) 2.61
Intracranial aneurysms in patients with subarachnoid hemorrhage: CT angiography as a primary examination tool for diagnosis--systematic review and meta-analysis. Radiology (2010) 2.60
Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol (2010) 2.50
International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol (2012) 2.45
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer. Eur Urol (2013) 2.43
Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol (2002) 2.30
Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst (2012) 2.30
Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet (2012) 2.29
Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol (2002) 2.27
Endoscopic ultrasound reduces surgical mediastinal staging in lung cancer: a randomized trial. Am J Respir Crit Care Med (2007) 2.26
What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiol Biomarkers Prev (2011) 2.25
CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax (2011) 2.20
Common and different genetic background for rheumatoid arthritis and coeliac disease. Hum Mol Genet (2009) 2.15
Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke (2003) 2.10
Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer. J Clin Oncol (2009) 2.06
Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ (2012) 2.05
Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study. J Clin Oncol (2006) 2.01
Reversal of vascular leak with imatinib. Am J Respir Crit Care Med (2013) 2.01
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med (2012) 1.99
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med (2012) 1.98
Aortic stiffness is associated with atherosclerosis of the coronary arteries in older adults: the Rotterdam Study. J Hypertens (2006) 1.98
Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study. Radiology (2013) 1.98
Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation (2011) 1.96
Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA (2011) 1.94
Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer (2005) 1.93
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States. Cancer Epidemiol Biomarkers Prev (2010) 1.93
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med (2011) 1.89
Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer (2006) 1.89
Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev (2011) 1.85
Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst (2008) 1.84
Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam. J Natl Cancer Inst (2010) 1.83
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial. Thorax (2011) 1.82
Genome-wide study of percent emphysema on computed tomography in the general population. The Multi-Ethnic Study of Atherosclerosis Lung/SNP Health Association Resource Study. Am J Respir Crit Care Med (2014) 1.80
Interpreting overdiagnosis estimates in population-based mammography screening. Epidemiol Rev (2011) 1.77
Patients' perceptions of the side-effects of prostate cancer treatment--a qualitative interview study. Soc Sci Med (2006) 1.76
Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography: systematic review and meta-analysis. Circ Cardiovasc Imaging (2013) 1.70
Additional double reading of screening mammograms by radiologic technologists: impact on screening performance parameters. J Natl Cancer Inst (2007) 1.69
Genome-wide association study of coronary and aortic calcification implicates risk loci for coronary artery disease and myocardial infarction. Atherosclerosis (2013) 1.69
Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur J Heart Fail (2006) 1.68
Stroke is associated with coronary calcification as detected by electron-beam CT: the Rotterdam Coronary Calcification Study. Stroke (2002) 1.66
Results of surgical treatment of T4 non-small cell lung cancer. Eur J Cardiothorac Surg (2003) 1.65
Computed tomography-quantified emphysema distribution is associated with lung function decline. Eur Respir J (2012) 1.65
Gleason score, age and screening: modeling dedifferentiation in prostate cancer. Int J Cancer (2006) 1.64
A cluster-randomized trial of screening for language delay in toddlers: effects on school performance and language development at age 8. Pediatrics (2007) 1.63
Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum (2007) 1.63
Pulmonary nodules detected at lung cancer screening: interobserver variability of semiautomated volume measurements. Radiology (2006) 1.63
Consolidative dendritic cell-based immunotherapy elicits cytotoxicity against malignant mesothelioma. Am J Respir Crit Care Med (2010) 1.60
The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension (2004) 1.59
Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. JACC Cardiovasc Imaging (2012) 1.59